vaccine patch

An artists impression of influenza molecules The molecules are blue and have multicolored centers
Pharma

Vaccine patch passes clinical test, supporting further trials

Vaxess linked the device to seroprotection rates of over 90% when used to administer an influenza vaccine in a phase 1 trial.
Nick Paul Taylor Dec 20, 2022 7:30am
business deal handshake

Institut Pasteur, Satio ally on intradermal vaccines for Africa

Aug 23, 2022 10:37am
MA

West takes stake in intradermal delivery startup Latch Medical

Aug 16, 2022 9:45am
Concept of SARS-CoV-2 or COVID-19

Vaxxas strikes deal to tee up trial of COVID-19 vaccine patch

Mar 29, 2022 9:04am
MyLife Technologies

MyLife raises cash to advance vaccine patch delivery tech

Nov 16, 2021 10:00am